Growth Metrics

Scholar Rock Holding (SRRK) Non-Current Assets (2017 - 2026)

Scholar Rock Holding's quarterly Non-Current Assets came in at $20.0 million in Q1 2026, down 10.47% year-on-year from $22.3 million in Q1 2025, and up 4.42% quarter-over-quarter from $19.1 million in Q4 2025.

Scholar Rock Holding has reported Non-Current Assets for 10 years, with the latest figure at $20.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 10.47% year-over-year to $20.0 million; the trailing twelve-month figure through Mar 2026 stood at $81.0 million (down 18.98% YoY), and the FY2025 full-year result was $19.1 million, down 19.5% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $20.0 million, up from $19.1 million in the prior quarter.
  • The five-year high for Non-Current Assets was $37.4 million in Q1 2022, with the low at $19.1 million in Q4 2025.
  • Average Non-Current Assets over 5 years is $25.5 million, with a median of $23.8 million recorded in 2024.
  • Year-over-year, Non-Current Assets slumped 32.02% in 2023 and increased 17.92% in 2024.
  • Tracing SRRK's Non-Current Assets over 5 years: stood at $30.1 million in 2022, then fell by 24.23% to $22.8 million in 2023, then gained by 4.01% to $23.8 million in 2024, then dropped by 19.5% to $19.1 million in 2025, then advanced by 4.42% to $20.0 million in 2026.
  • The last three Non-Current Assets figures came in at $20.0 million (Q1 2026), $19.1 million (Q4 2025), and $21.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 4.56 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 62,953.78
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 5.83 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.75 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 22.66 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 910.24 Mn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - 19.97 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 19.97 Mn
Dec 31, 2025 19.13 Mn
Sep 30, 2025 21.01 Mn
Jun 30, 2025 20.92 Mn
Mar 31, 2025 22.31 Mn
Dec 31, 2024 23.76 Mn
Sep 30, 2024 26.21 Mn
Jun 30, 2024 27.73 Mn
Mar 31, 2024 20.35 Mn
Dec 31, 2023 22.84 Mn
Sep 30, 2023 22.22 Mn
Jun 30, 2023 25.09 Mn
Mar 31, 2023 27.56 Mn
Dec 31, 2022 30.14 Mn
Sep 30, 2022 32.69 Mn
Jun 30, 2022 34.99 Mn
Mar 31, 2022 37.39 Mn
Dec 31, 2021 39.13 Mn
Sep 30, 2021 40.23 Mn
Jun 30, 2021 41.69 Mn
Mar 31, 2021 42.09 Mn
Dec 31, 2020 43.90 Mn
Sep 30, 2020 44.04 Mn
Jun 30, 2020 11.17 Mn
Mar 31, 2020 11.53 Mn
Dec 31, 2019 11.21 Mn
Sep 30, 2019 9.30 Mn
Jun 30, 2019 8.53 Mn
Mar 31, 2019 8.95 Mn
Dec 31, 2018 3.40 Mn
Sep 30, 2018 2.83 Mn
Jun 30, 2018 2.06 Mn
Dec 31, 2017 2.44 Mn